Q2 2025 |
45 |
$470M |
+$25.6M |
-$70.2M |
-$44.6M |
INSM, ACAD, BMRN, FOLD, UTHR
|
13F-HR |
8/14/2025, 05:14 PM |
Q1 2025 |
44 |
$525M |
+$25.3M |
-$112M |
-$87.2M |
INSM, BMRN, FOLD, ACAD, UTHR
|
13F-HR |
5/15/2025, 04:39 PM |
Q4 2024 |
43 |
$645M |
+$21.6M |
-$83.5M |
-$61.9M |
INSM, FOLD, BMRN, UTHR, ACAD
|
13F-HR |
2/14/2025, 04:18 PM |
Q3 2024 |
45 |
$770M |
+$71.7M |
-$110M |
-$37.9M |
INSM, FOLD, BMRN, UTHR, BIIB
|
13F-HR |
11/14/2024, 04:11 PM |
Q2 2024 |
39 |
$818M |
+$2.21M |
-$189M |
-$187M |
INSM, BMRN, FOLD, UTHR, BIIB
|
13F-HR |
8/14/2024, 04:18 PM |
Q1 2024 |
36 |
$879M |
+$35M |
-$131M |
-$96.5M |
INSM, FOLD, BMRN, BIIB, UTHR
|
13F-HR |
5/15/2024, 04:10 PM |
Q4 2023 |
33 |
$1.1B |
+$86.4M |
-$89.5M |
-$3.07M |
INSM, FOLD, BMRN, BIIB, UTHR
|
Restatement |
2/15/2024, 02:34 PM |
Q3 2023 |
30 |
$1.06B |
+$10.7M |
-$21M |
-$10.2M |
BMRN, INSM, UTHR, FOLD, BIIB
|
13F-HR |
11/14/2023, 04:41 PM |
Q2 2023 |
32 |
$1.24B |
+$40.4M |
-$12.3M |
+$28.2M |
BMRN, UTHR, RVNC, FOLD, INSM
|
13F-HR |
8/14/2023, 05:24 PM |
Q1 2023 |
30 |
$1.21B |
+$18.8M |
-$9.87M |
+$8.89M |
BMRN, RVNC, UTHR, FOLD, BIIB
|
13F-HR |
5/15/2023, 05:06 PM |
Q4 2022 |
29 |
$1.17B |
+$59.8M |
-$29M |
+$30.7M |
BMRN, UTHR, FOLD, INSM, BIIB
|
13F-HR |
2/14/2023, 03:39 PM |
Q3 2022 |
32 |
$1.26B |
+$3.02M |
-$14.2M |
-$11.2M |
BMRN, UTHR, INSM, ABMD, RVNC
|
13F-HR |
11/14/2022, 03:28 PM |
Q2 2022 |
33 |
$1.15B |
+$22.7K |
-$24.7M |
-$24.7M |
BMRN, UTHR, ABMD, INSM, FOLD
|
13F-HR |
8/15/2022, 05:31 PM |
Q1 2022 |
35 |
$1.29B |
+$7.47M |
-$44.6M |
-$37.1M |
BMRN, ABMD, INSM, UTHR, FOLD
|
13F-HR |
5/16/2022, 04:35 PM |
Q4 2021 |
37 |
$1.56B |
+$54.4M |
-$42.4M |
+$11.9M |
BMRN, ABMD, INSM, UTHR, FOLD
|
13F-HR |
2/14/2022, 03:28 PM |
Q3 2021 |
42 |
$1.66B |
+$28.5M |
-$48.2M |
-$19.7M |
ABMD, BMRN, INSM, STAA, UTHR
|
13F-HR |
11/15/2021, 04:19 PM |
Q2 2021 |
42 |
$1.81B |
+$25.7M |
-$110M |
-$83.9M |
STAA, BMRN, ABMD, INSM, BIIB
|
13F-HR |
8/16/2021, 04:36 PM |
Q1 2021 |
42 |
$1.76B |
+$144M |
-$192M |
-$47.4M |
INSM, STAA, ABMD, BMRN, UTHR
|
13F-HR |
5/17/2021, 04:37 PM |
Q4 2020 |
41 |
$1.91B |
+$224M |
-$651K |
+$223M |
STAA, INSM, BMRN, FOLD, ABMD
|
13F-HR |
2/16/2021, 03:33 PM |
Q3 2020 |
42 |
$1.82B |
+$140M |
-$152M |
-$11.2M |
IMMU, INSM, STAA, ABMD, BMRN
|
13F-HR |
11/16/2020, 03:23 PM |
Q2 2020 |
41 |
$1.67B |
+$40.7M |
-$103M |
-$62.4M |
IMMU, STAA, BMRN, INSM, ABMD
|
13F-HR |
8/14/2020, 04:15 PM |
Q1 2020 |
37 |
$1.19B |
+$10.4M |
-$263M |
-$252M |
BMRN, STAA, INSM, EPZM, UTHR
|
13F-HR |
5/15/2020, 04:09 PM |
Q4 2019 |
37 |
$1.82B |
+$8.66M |
-$129M |
-$120M |
BMRN, INSM, EPZM, STAA, IMMU
|
Restatement |
4/8/2020, 04:35 PM |
Q3 2019 |
37 |
$1.5B |
|
-$161M |
-$161M |
BMRN, INSM, ABMD, UTHR, STAA
|
13F-HR |
11/14/2019, 03:14 PM |
Q2 2019 |
38 |
$2.06B |
+$22.7M |
-$71.8M |
-$49.1M |
BMRN, INSM, ABMD, SAGE, ALXN
|
13F-HR |
8/14/2019, 04:17 PM |
Q1 2019 |
37 |
$2.4B |
+$138M |
-$25.1M |
+$113M |
BMRN, INSM, ABMD, UTHR, ALXN
|
Restatement |
7/30/2019, 12:25 PM |
Q4 2018 |
36 |
$1.88B |
+$78.5M |
-$31.5M |
+$47M |
ABMD, BMRN, UTHR, STAA, ALXN
|
13F-HR |
2/14/2019, 03:25 PM |
Q3 2018 |
36 |
$2.47B |
+$25M |
-$96M |
-$71M |
ABMD, BMRN, UTHR, STAA, ALXN
|
13F-HR |
11/14/2018, 03:29 PM |
Q2 2018 |
36 |
$2.5B |
+$77.1M |
-$198M |
-$121M |
ABMD, BMRN, CLVSQ, UTHR, INSM
|
13F-HR |
8/14/2018, 04:28 PM |
Q1 2018 |
36 |
$2.34B |
+$84.4M |
-$72.5M |
+$11.8M |
ABMD, CLVSQ, BMRN, UTHR, INSM
|
13F-HR |
5/15/2018, 04:28 PM |
Q4 2017 |
37 |
$2.32B |
+$89.5M |
-$124M |
-$34.1M |
ABMD, UTHR, CLVSQ, BMRN, INSM
|
13F-HR |
2/14/2018, 04:00 PM |
Q3 2017 |
39 |
$2.37B |
+$60.1M |
-$53.5M |
+$6.61M |
ABMD, CLVSQ, BMRN, UTHR, INSM
|
13F-HR |
11/14/2017, 03:40 PM |
Q2 2017 |
38 |
$2.14B |
+$54.8M |
-$61.6M |
-$6.78M |
CLVSQ, ABMD, UTHR, BMRN, ALXN
|
13F-HR |
8/14/2017, 04:41 PM |
Q1 2017 |
39 |
$2.12B |
+$207M |
|
+$207M |
UTHR, CLVSQ, ABMD, BMRN, ALXN
|
13F-HR |
5/15/2017, 04:33 PM |
Q4 2016 |
38 |
$1.75B |
+$95.5M |
-$12.6M |
+$82.8M |
UTHR, ABMD, CLVSQ, BMRN, AMAG
|
13F-HR |
2/14/2017, 04:36 PM |
Q3 2016 |
42 |
$1.72B |
+$99.5M |
-$27.4M |
+$72.1M |
ABMD, UTHR, BMRN, CLVSQ, AMAG
|
13F-HR |
11/14/2016, 03:49 PM |
Q2 2016 |
45 |
$1.32B |
+$227M |
-$43.5M |
+$184M |
ABMD, UTHR, BMRN, AMAG, CLVSQ
|
Restatement |
8/15/2016, 05:46 PM |
Q1 2016 |
44 |
$1.29B |
+$21.6M |
-$55.5M |
-$34M |
ABMD, UTHR, ANAC, BMRN, AMAG
|
13F-HR |
5/16/2016, 05:15 PM |
Q4 2015 |
43 |
$1.8B |
+$138M |
-$82.5M |
+$55.1M |
ABMD, ANAC, UTHR, BMRN, CLVSQ
|
13F-HR |
2/16/2016, 04:00 PM |
Q3 2015 |
47 |
$2.08B |
+$185M |
-$227M |
-$42.1M |
ANAC, CLVSQ, ABMD, UTHR, BMRN
|
13F-HR |
11/16/2015, 03:28 PM |
Q2 2015 |
45 |
$2.25B |
+$80.5M |
-$35M |
+$45.5M |
UTHR, ANAC, BMRN, CLVSQ, ABMD
|
13F-HR |
8/14/2015, 04:36 PM |
Q1 2015 |
45 |
$2.02B |
+$372M |
-$95.5M |
+$277M |
UTHR, BMRN, ANAC, ABMD, CLVSQ
|
13F-HR |
5/15/2015, 05:11 PM |
Q4 2014 |
46 |
$1.7B |
+$177M |
-$85.8M |
+$91.1M |
UTHR, AUXL, CBST, CLVSQ, BMRN
|
13F-HR |
2/17/2015, 04:18 PM |
Q3 2014 |
43 |
$1.34B |
+$235M |
-$21.3M |
+$214M |
UTHR, AUXL, CBST, BMRN, CYBX
|
13F-HR |
11/13/2014, 01:40 PM |
Q2 2014 |
42 |
$1.34B |
+$203M |
-$79.3M |
+$124M |
ITMN, UTHR, CYBX, CBST, AUXL
|
13F-HR |
8/13/2014, 07:45 PM |
Q1 2014 |
39 |
$1.21B |
|
|
|
ITMN, AUXL, CYBX, UTHR, CBST
|
New Holdings |
5/15/2014, 06:36 PM |
Q1 2014 |
39 |
$1.21B |
+$60.9M |
-$45.7M |
+$15.2M |
ITMN, AUXL, CYBX, UTHR, CBST
|
13F-HR |
5/15/2014, 04:46 PM |
Q4 2013 |
34 |
$1.07B |
|
|
|
CYBX, UTHR, AUXL, CBST, ABMD
|
13F-HR |
2/13/2014, 04:04 PM |